Table 2.
Number of isolates and antimicrobials sensitivity of major HcA- and CA-MRSA strains, according to spa types∗.
| N | Trimethoprim/sulfamethoxazole | Vancomycin | Ciprofloxacin | Erythromycin | Clindamycin | Rifampicin | Daptomycin | Mupirocin | |
|---|---|---|---|---|---|---|---|---|---|
| Classical HcA-MRSA strains | |||||||||
| t002 | 52 | 96 (48/50) | 100 (49/49) | 4 (2/45) | 12 (6/51) | 15 (8/52) | 100 (47/47) | 100 (13/13) | 62 (8/13) |
| t001 | 11 | 100 (11/11) | 100 (11/11) | 10 (1/10) | 9 (1/11) | 9 (1/11) | 100 (11/11) | −(0) | 100 (2/2) |
| t10509 | 4 | 100 (4/4) | 100 (4/4) | 0 (0/4) | 0 (0/4) | 0 (0/4) | 100 (4/4) | −(0) | −(0) |
| t9501 | 4 | 100 (4/4) | 100 (4/4) | 0 (0/4) | 0 (0/4) | 0 (0/4) | 100 (4/4) | −(0) | 100 (1/1) |
| Total | 73 | 97 (67/69) | 100 (68/68) | 5 (3/63) | 10 (7/70) | 13 (9/71) | 100 (66/66) | 100 (13/13) | 69 (11/16) |
| Classical CA-MRSA strains | |||||||||
| t032 | 29 | 100 (29/29) | 100 (28/28) | 8 (2/26) | 86 (25/29) | 83 (24/29) | 100 (28/28) | 100 (1/1) | 100 (3/3) |
| t008 | 12 | 100 (12/12) | 100 (12/12) | 10 (1/10) | 75 (9/12) | 92 (11/12) | 100 (12/12) | 100 (2/2) | 100 (2/2) |
| t065 | 11 | 100 (11/11) | 100 (11/11) | 0 (0/11) | 100 (11/11) | 100 (11/11) | 100 (11/11) | 100 (8/8) | 100 (7/7) |
| t578 | 9 | 100 (9/9) | 100 (9/9) | 0 (0/9) | 100 (9/9) | 100 (9/9) | 100 (9/9) | 100 (6/6) | 12 (1/8) |
| t14221 | 6 | 16 (1/6) | 100 (6/6) | 0 (0/6) | 100 (6/6) | 100 (6/6) | 100 (6/6) | −(0) | −(0) |
| t2113 | 2 | 100 (2/2) | 100 (2/2) | 0 (0/2) | 100 (2/2) | 100 (2/2) | 100 (2/2) | −(0) | −(0) |
| t5490 | 2 | 100 (2/2) | 100 (2/2) | 0 (0/1) | 50 (1/2) | 50 (1/2) | 100 (2/2) | −(0) | −(0) |
| Total | 71 | 93 (66/71) | 100 (70/70) | 5 (3/65) | 89 (63/71) | 90 (64/71) | 100 (70/70) | 100 (17/17) | 65 (13/20) |
∗Percentages of sensitive strains are presented. Parentheses include the number of sensitive isolates/number of isolates tested.